Expression analysis of the PMP22 gene in glioma and osteogenic sarcoma cell lines

Citation
K. Huhne et al., Expression analysis of the PMP22 gene in glioma and osteogenic sarcoma cell lines, J NEUROSC R, 58(5), 1999, pp. 624-631
Citations number
36
Categorie Soggetti
Neurosciences & Behavoir
Journal title
JOURNAL OF NEUROSCIENCE RESEARCH
ISSN journal
03604012 → ACNP
Volume
58
Issue
5
Year of publication
1999
Pages
624 - 631
Database
ISI
SICI code
0360-4012(199912)58:5<624:EAOTPG>2.0.ZU;2-N
Abstract
Previously me reported the amplification of the peripheral myelin protein 2 2 (PMP22) gene in cell lines of human osteogenic and glioma tumors. PMP22 n ormally is expressed at high levels in Schwann cells of the peripheral nerv ous system and is suggested to function as a structural protein of the myel in sheath. One of the most common inherited peripheral neuropathies, Charco t-Marie-Tooth Type 1A (CMT1A), is associated with a duplication of a 1.5-Mb DNA region on chromosome 17p11.2-p12 containing PMP22. On the other hand, PMP22 is identical to gas3, whose expression is induced in growth-arresting NIH3T3-fibroblasts and is thought to play a role in cell proliferation. Th e precise role of gas3/PMP22 remains to be determined, Here we show that in the tumor cell lines RH30 and SF763 the amplified region including PMP22 c omprises the whole 1.5-Mb CMT1A region. We could prove expression of PMP22 by reverse transcriptase-polymerase chain reaction (RT-PCR) and discovered an unusual PMP22 transcript in these tumor cell lines. Western blot analyse s resulted in detection of a 22-kDa protein by the PMP22-specific antibody 558/2 and in exclusion of myelin protein zero (MPZ) expression in these cel l lines. (C) 1999 Wiley-Liss, Inc.